Tobias Schümmer

Dr. Tobias Schümmer, ERT

Senior Toxicologist

Fresenius-Kabi

Tobias Schümmer is a biochemist and toxicologist with more than 10 years of experience in the pharmaceutical industry. After a Ph.D. in physical biochemistry from the Technische Universität München, he stayed as a Post-Doc at the Alberta RNA Research and Training Institute in Canada. Tobias started working in the field of early pharmaceutical development at a generics and medical device company. In parallel, he obtained a degree in toxicology and environmental protection from Universität Leipzig. Since October 2022, Tobias is a toxicologist at Fresenius Kabi where he is working in the field of impurities with special focus on nitrosamines.

Speaked About
December 2, 2026
Explore 2026 EMA trends, AI risk mapping, ppb-level LC-MS/MS, and advanced mitigation for nitrosamines and genotoxic impurity compliance.
Upcoming

DAY 2: December 2nd, 2026

SESSION: Nitrosamine Sources Beyond the API: The Role of Container Closure Systems

◆  Regulatory background for the requirement of nitrosamine risk assessments for nitrosamines originating from container closure systems.

◆  Differentiation between nitrosamines formed in the raw material and formed during the shelf-life of the drug product (short excursion to Jost et al. (2026)).

◆  Identification of nitrosamines at risk.

◆  General considerations on nitrosamine risk assessments.

Speaker Details
Speaker Details